- Verrica Pharmaceuticals (NASDAQ:VRCA): Q3 GAAP EPS of -$0.27 misses by $0.03.
- Cash, cash equivalents and marketable securities of $96.98M
- Press Release
Verrica Pharmaceuticals misses by $0.03
Recommended For You
More Trending News
About VRCA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
VRCA | - | - |
Verrica Pharmaceuticals Inc. |